Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Medite Cancer Diagnostics, Inc. | ex99-1.htm |
| EX-10.1 - EXECUTIVE EMPLOYMENT AGREEMENT - Medite Cancer Diagnostics, Inc. | ex10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of report (Date of earliest event reported) April 24,
2017
MEDITE CANCER DIAGNOSTICS, INC.
(Exact
Name of Registrant as Specified in Charter)
Delaware
(State
or Other Jurisdiction of Incorporation)
|
333-143570
|
36-4296006
|
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
4203 SW 34th St.
|
|
|
Orlando,
FL
|
32811
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
(407) 996-9630
(Registrant’s
telephone number, including area code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers
On April 24, 2017, the
Board of Directors (the “Board”) of MEDITE Cancer
Diagnostics, Inc. (the “Company”) held a meeting
whereby it unanimously voted to appoint Susan Weisman to the
position of Chief Financial Officer of the Company to serve until
such time as his removal or resignation. Pursuant to Ms.
Weisman’s Executive Employment Agreement with the Company,
the Commencement Date of her appointment shall be April 26, 2017.
She shall receive an annual base salary of $120,000. She shall also
be granted 200,000 restricted shares of the Company’s common
stock (the “Shares”). The
Shares will vest in three (3) equal installments on each of
the first three annual anniversary dates of Ms. Weisman’s
appointment, so long as she remains employed by the Company through
each such vesting date. Ms. Weisman shall also be entitled to
annual performance bonuses, benefits and vacation in accordance
with the Company’s current policy.
Susan Weisman. Age 56, Chief Financial Officer
Susan
Weisman is a Finance Executive with over 30 years of progressive
experience in consulting, executive positions with both public and
private companies and various industries, including financial
services, technology, real estate, medical services and
manufacturing. She has an extensive history of increasing
responsibility, achievement of growth in all positions across
product/service/technology. From August 2008 until the present, Ms.
Weisman operated Finance and Strategic Consultants, LLC, where she
provided advisory services to the Company as well as a healthcare
service provider and a healthcare technology, various other
technology companies, financial services companies as well as real
estate and various other industries. From September 20008 to
October 2010 Ms. Weisman worked for AFC, LLC., an investment
company of Mitsui & Co (USA) as Chief Financial Officer, Acting
Chief Executive Officer and Chief Liquidation Officer a sub-prime
auto finance company reporting to Mitsui & Co (USA). From
September 2007 to August 2008, Ms. Weisman was the Chief Financial
Officer and Chief Operating Officer for CU Business Capital, LLC.
From 2004 to 2007, a credit union service organization. Ms. Weisman
was Chief Financial Officer and Director of Coach Industries Group,
a company required to file reports with the Securities and Exchange
Commission, a financial services company offering lease finance,
insurance, independent contractor settlement to commercial fleet
operators, as well as the manufacturer of modified commercial
vehicles. From 1990 to 2000, Ms. Weisman was Controller and acting
CFO of a $4.2 Billion savings bank holding company, BankAtlantic
Bancorp, a company required to file reports with the Securities and
Exchange Commission which included BankAtlantic, a federal savings
bank, BankAtlantic Development Corporation, a real estate
development company, Ryan, Beck & Co. an investment banking
company and various internet start-up investments. From 1986 to
1990 Ms. Weisman worked for KPMG, LLC, a global accounting firm.
Ms. Weisman obtained a B.S. Degree in Economics from City
University of New York - Brooklyn College. Ms. Weisman is a
certified public accountant – New York (inactive status).
Except as set forth above, Ms. Weisman has not served as an officer
and director of a company required to file reports with the
Securities and Exchange Commission.
Item 9.01 Financial Statements and
Exhibits
|
Exhibit
No.
|
|
Description
|
|
10.1
|
|
Executive Employment
Agreement
|
|
|
|
|
|
99.1
|
|
Press
Release
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
MEDITE
CANCER DIAGNOSTICS, INC.
|
|
|
|
|
|
|
|
|
|
|
Date:
April 27, 2017
|
By:
|
/s/ David Patterson
|
|
|
|
David
Patterson
|
|
|
|
Chief
Executive Officer
|